183 related articles for article (PubMed ID: 37080606)
41. Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer.
Robinson CG; DeWees TA; El Naqa IM; Creach KM; Olsen JR; Crabtree TD; Meyers BF; Puri V; Bell JM; Parikh PJ; Bradley JD
J Thorac Oncol; 2013 Feb; 8(2):192-201. PubMed ID: 23287852
[TBL] [Abstract][Full Text] [Related]
42. Outcomes of sublobar resection vs lobectomy for invasive clinical stage T1N0 non-small-cell lung cancer: A propensity-match analysis.
Wald O; Sadeh BM; Bdolah-Abram T; Erez E; Shapira OM; Izhar U
Cancer Rep (Hoboken); 2021 Jun; 4(3):e1339. PubMed ID: 33570255
[TBL] [Abstract][Full Text] [Related]
43. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer.
Crabtree TD; Denlinger CE; Meyers BF; El Naqa I; Zoole J; Krupnick AS; Kreisel D; Patterson GA; Bradley JD
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):377-86. PubMed ID: 20400121
[TBL] [Abstract][Full Text] [Related]
44. Adverse Events Following Limited Resection versus Stereotactic Body Radiation Therapy for Early Stage Lung Cancer.
Wang Q; Stone K; Kern JA; Slatore CG; Swanson S; Blackstock W; Khan RS; Smith CB; Veluswamy RR; Chidel M; Wisnivesky JP
Ann Am Thorac Soc; 2022 Dec; 19(12):2053-2061. PubMed ID: 35816617
[No Abstract] [Full Text] [Related]
45. Interpreting survival data from clinical trials of surgery versus stereotactic body radiation therapy in operable Stage I non-small cell lung cancer patients.
Samson P; Keogan K; Crabtree T; Colditz G; Broderick S; Puri V; Meyers B
Lung Cancer; 2017 Jan; 103():6-10. PubMed ID: 28024698
[TBL] [Abstract][Full Text] [Related]
46. Surgical Outcomes for Early Stage Non-small Cell Lung Cancer at Facilities With Stereotactic Body Radiation Therapy Programs.
Syed YA; Stokes W; Rupji M; Liu Y; Khullar O; Sebastian N; Higgins K; Bradley JD; Curran WJ; Ramalingam S; Taylor J; Sancheti M; Fernandez F; Moghanaki D
Chest; 2022 Mar; 161(3):833-844. PubMed ID: 34785235
[TBL] [Abstract][Full Text] [Related]
47. Comparison of Long-term Survival of Patients With Early-Stage Non-Small Cell Lung Cancer After Surgery vs Stereotactic Body Radiotherapy.
Chi A; Fang W; Sun Y; Wen S
JAMA Netw Open; 2019 Nov; 2(11):e1915724. PubMed ID: 31747032
[TBL] [Abstract][Full Text] [Related]
48. Overall survival in low-comorbidity patients with stage I non-small cell lung cancer who chose stereotactic body radiotherapy compared to surgery.
Udelsman BV; Canavan ME; Zhan PL; Ely S; Park HS; Boffa DJ; Mase VJ
J Thorac Cardiovasc Surg; 2024 Mar; 167(3):822-833.e7. PubMed ID: 37500052
[TBL] [Abstract][Full Text] [Related]
49. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis.
Palma D; Visser O; Lagerwaard FJ; Belderbos J; Slotman BJ; Senan S
J Clin Oncol; 2010 Dec; 28(35):5153-9. PubMed ID: 21041709
[TBL] [Abstract][Full Text] [Related]
50. Video-assisted thoracic lobectomy
Detillon DDEMA; Aarts MJ; De Jaeger K; Van Eijck CHJ; Veen EJ
Eur Respir J; 2019 Jun; 53(6):. PubMed ID: 30923188
[TBL] [Abstract][Full Text] [Related]
51. Surgery or stereotactic body radiotherapy for elderly stage I lung cancer? A propensity score matching analysis.
Miyazaki T; Yamazaki T; Nakamura D; Sato S; Yamasaki N; Tsuchiya T; Matsumoto K; Kamohara R; Hatachi G; Nagayasu T
Surg Today; 2017 Dec; 47(12):1476-1483. PubMed ID: 28447170
[TBL] [Abstract][Full Text] [Related]
52. Sins of omission: A meta-research study evaluating the omission of operability in published retrospective comparisons of surgery with stereotactic body radiotherapy in patients with early-stage non-small cell lung cancer.
Lorenz J; Moghanaki D; Keshava H; Harpole DH; Bradley JD; Higgins KA; Rusthoven CG; Stokes WA
Lung Cancer; 2023 Jan; 175():57-59. PubMed ID: 36455397
[TBL] [Abstract][Full Text] [Related]
53. Stereotactic Body Radiation Therapy Versus Surgery for Early Lung Cancer Among US Veterans.
Bryant AK; Mundt RC; Sandhu AP; Urbanic JJ; Sharabi AB; Gupta S; Daly ME; Murphy JD
Ann Thorac Surg; 2018 Feb; 105(2):425-431. PubMed ID: 29198624
[TBL] [Abstract][Full Text] [Related]
54. Sublobar Resection, Radiofrequency Ablation or Radiotherapy in Stage I Non-Small Cell Lung Cancer.
Safi S; Rauch G; op den Winkel J; Kunz J; Schneider T; Bischof M; Heussel CP; Huber PE; Herth FJ; Dienemann H; Hoffmann H
Respiration; 2015; 89(6):550-7. PubMed ID: 25968471
[TBL] [Abstract][Full Text] [Related]
55. Comparison of the outcomes of stereotactic body radiotherapy and surgery in elderly patients with cT1-2N0M0 non-small cell lung cancer.
Nakagawa T; Negoro Y; Matsuoka T; Okumura N; Dodo Y
Respir Investig; 2014 Jul; 52(4):221-6. PubMed ID: 24998368
[TBL] [Abstract][Full Text] [Related]
56. Survival of Primary Stereotactic Body Radiation Therapy Compared With Surgery for Operable Stage I/II Non-small Cell Lung Cancer.
Khorfan R; Kruser TJ; Coughlin JM; Bharat A; Bilimoria KY; Odell DD
Ann Thorac Surg; 2020 Jul; 110(1):228-234. PubMed ID: 32147416
[TBL] [Abstract][Full Text] [Related]
57. Surgery versus stereotactic body radiotherapy for clinical stage I non-small-cell lung cancer: propensity score-matching analysis including the ratio of ground glass nodules.
Tomita N; Okuda K; Osaga S; Miyakawa A; Nakanishi R; Shibamoto Y
Clin Transl Oncol; 2021 Mar; 23(3):638-647. PubMed ID: 32705493
[TBL] [Abstract][Full Text] [Related]
58. A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer.
Yerokun BA; Yang CJ; Gulack BC; Li X; Mulvihill MS; Gu L; Wang X; Harpole DH; D'Amico TA; Berry MF; Hartwig MG
J Thorac Cardiovasc Surg; 2017 Aug; 154(2):675-686.e4. PubMed ID: 28461054
[TBL] [Abstract][Full Text] [Related]
59. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.
Haidar YM; Rahn DA; Nath S; Song W; Bazhenova L; Makani S; Fuster MM; Sandhu AP
Ther Adv Respir Dis; 2014 Feb; 8(1):3-12. PubMed ID: 24334338
[TBL] [Abstract][Full Text] [Related]
60. Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Stage I Medically Inoperable Small Cell Lung Carcinoma: A Multi-Institutional Analysis From the RSSearch Patient Registry.
Singh R; Ansinelli H; Sharma D; Jenkins J; Davis J; Vargo JA; Sharma S
Am J Clin Oncol; 2019 Jul; 42(7):602-606. PubMed ID: 31232723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]